Fundraising FoxDiamond Edge Ventures — Full Portfolio
18 tracked investments · listed companies and verified rows first
Licella is a developer of hydrothermal liquefaction technology that converts low-cost waste biomass into advanced biofuels, including sustainable aviation fuel (SAF), renewable diesel, and biomaterials.
BiotechCircular EconomyCleantechEnergyNorth Sydney, AU
Dr Len Humphreys(Executive Chairman)Professor Thomas Maschmeyer AO
iAM Marketplace is an online marketplace for additive manufacturing, offering materials such as filaments, photopolymers, and powders alongside hardware, accessories, certified pre-owned equipment, and related services and solutions.
Advanced ManufacturingB2B MarketplacesNew Materials
Co-investorsWest Hill Capital
BO Materials develops novel materials for industrial applications across trillion-dollar industries.
AI & Machine LearningDeep TechNew MaterialsSemiconductorsMassachusetts, US
Michael Segal(Executive Officer, Director)inAnvesh Gurijala(Founder)
BoardDavid Miller(Director)inDwight Poler(Director)Andrew Goldman(Director)
Co-investorsAccelr8ACVC PartnersClean Energy VentureClean Energy VenturesCollaborative FundGC Ventures+5 more
Plant-based meat 'Miracle Meat' from germinated soybeans
Co-investorsGlobal BrainKDDI Open Innovation Fund
DigiLens develops waveguide optics and holographic display technology using a proprietary material set combined with inkjet printing and a holographic contact copy process.
Deep TechHardwareNew MaterialsSunnyvale, US
Jonathan Waldern(Director)inChristopher Pickett(Executive Officer, Director)Patrick Suel(Director)Robert Young(Director)Thorsten Alexander Kern(Director)
BoardJim Whims(Director)
Co-investorsAlsop Louie PartnersBold Capital PartnersDolby Family VenturesIn-Q-TelNautilus Ventures Management Company (Us), LlcSony Ventures Corporation+2 more
Lingrove designs and manufactures Ekoa, a bio-based composite made from renewable flax and plant resins used as impact-resistant wall protection, wall coverings, ceilings, and millwork for hospitality, healthcare, senior living, and workplace interiors.
CleantechConstruction TechNew Materials
Joe Luttwak(Founder)
Co-investorsSnatched VenturesSoundboard Venture FundIndieBioMayfield FundSOSV
Eridan builds Software Defined Radios for Private 5G networks, using a proprietary Switch-Mode Direct Polar transmitter with Gallium Nitride power stages to deliver higher signal fidelity and lower power consumption than conventional radios.
AI & Machine LearningDeep TechEnterprise SoftwareHardwareIoTRoboticsSemiconductorsSunnyvale, US
Doug Kirkpatrick(Founder)inVivek Pathak(Executive Officer)inDouglas A Kirkpatrick(Executive Officer, Director)Amy Lamboley(Executive Officer)inSusan Kamin(Executive Officer)Paul Draxler(Executive Officer)in
Co-investorsEvolution VC PartnersMonta Vista CapitalPage One VenturesRising TideSand Hill AngelsSilicon Catalyst+3 more
Yokogawa Fluence Analytics develops patented process analytics and control technologies, including its ACOMP system for real-time polymer reaction monitoring and its ARGEN static light scattering instrument for biopolymer stability testing.
Advanced ManufacturingAI & Machine LearningBiotechHardwareIoT
Co-investorsEnergy Innovation CapitalMITSUBISHI CHEMICAL
Freshr Technologies develops active packaging technology designed to extend the shelf life of fresh food and reduce waste.
Circular EconomyCleantechFoodTechNew Materials
Dr. Mina Mekhail(Founder and CEO)
Co-investorsNàdarra Ventures
Lactips produces natural, biobased polymers derived from protein that are biodegradable and water-soluble, addressing microplastic pollution across industrial applications.
Circular EconomyCleantechNew MaterialsSaint-Paul-en-Jarez, FR
Co-investorsBlue Ocean Capital GroupBNP Paribas DéveloppementBpifranceDemeterGO CapitalSWEN Capital Partners
Lingrove designs and manufactures Ekoa, a bio-based composite material made from flax and plant resins used as wall protection, wall coverings, ceilings, and millwork for hospitality, healthcare, and workplace interiors, as well as automotive interior applications.
CleantechConstruction TechNew MaterialsSan Rafael, US
Joseph Luttwak(Executive Officer, Director)in
BoardTalley Goodson(Director)Thomas Crow(Director)Stephen P. Welker(Director)
Co-investorsBioGenerator VenturesBoro CapitalCool Climate CollectiveGaingelsSeaX VenturesSOSV+5 more
__Twitter.png)
Myoridge develops serum-free cell culture media and optimization services for cell cultivation and regenerative medicine applications.
BiotechHealthtechMedical DevicesJapan, JP
Co-investorsBeyond Next VenturesKyoto University Innovation Capital
Outrun Therapeutics is a preclinical biotech developing small molecule E3 ligase inhibitors to stabilise tumour suppressor proteins for treating cancer and other diseases.
BiotechDeep TechDundee, GB
Satpal Virdee(Founder)
Co-investorsM VenturesMC Healthcare Ventures
PharmEnable applies AI to small molecule drug discovery, focusing on challenging and data-sparse biological targets that traditional methods struggle to address.
AI & Machine LearningBiotechDeep Tech
Hannah Sore(Founder)in
Co-investorsCambridge Angels groupMartlet CapitalMC Healthcare VenturesO2h VenturesParkwalk AdvisorsWren Capital
Prime Roots makes plant-based deli meats designed to match conventional meat in blind taste tests, using clean ingredients without nitrates or celery salt.
ConsumerFoodTech
Kimberlie Le(Founder)inJoshua Nixon(Founder)
Co-investorsAlumni VenturesCollaborative FundDnx VenturesGaingelsPangaea Ventures Us Inc.Portfolia+9 more
QurAlis develops precision therapies for amyotrophic lateral sclerosis (ALS) and related neurodegenerative diseases by targeting specific disease-causing genetic drivers and molecular mechanisms.
BiotechDeep TechMedical DevicesCambridge, US
Kevin Eggan(Founder, QurAlis; Group Vice President, Head of Research and Early Development, BioMarin Pharmaceutical)inRoet(Co-founder)Woolf(Co-founder)Kasper Roet(Founder, Chief Executive Officer)inShafique Virani(Executive Officer)inJason Brown(Mr. Brown is the Chief Financial Officer of the Issuer.)in
Co-investorsALS Investment FundDolby Family VenturesDroia VenturesInkefMC Healthcare VenturesMission Biocapital+8 more
TRIMTech Therapeutics is a biotechnology company focused on drug discovery and development, backed by investors including Cambridge Innovation Capital and BGF.
BiotechDeep TechLongevityMedical DevicesCambridge, GB
Damian Crowther, PhD FRCP(Co-founder, Head of Research)Dr. Leo James(Co-founder, Group Leader at MRC Laboratory of Molecular Biology)Dr. William McEwan(Co-founder, Group Leader at UK Dementia Research Institute, University of Cambridge)Nicki Thompson, PhD(CEO)Nicki Thompson(CEO)
Co-investorsCambridge Innovation CapitalPfizer VenturesSV Health InvestorsM VenturesPfizer Venture InvestmentsStart Codon
Advanced ManufacturingCleantechGolden, US
Andrew Maxey(Executive Officer, Director)inAaron Parker(Executive Officer)inDaniel Flagg(Executive Officer)inSean Kline(Executive Officer)inShari Kennett(Director)J. Scott Pusey(Executive Officer)
Co-investorsAutodesk FoundationBelle Impact FundBeyond CapitalCircular Innovation FundE8 AngelsHG Ventures+8 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.